vancomycin has been researched along with 2019 Novel Coronavirus Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 18 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lippmann, N; Lübbert, C; Stîngu, CS; Wendt, S; Wiegand, J | 1 |
| Calais, LA; Climo, MW; Donskey, CJ; Ge, L; Gerding, DN; Goetz, MB; Goldberg, AM; Gordin, FM; Gupta, K; Haegerich, T; Johnson, M; Johnson, N; Johnson, S; Li, X; Reda, DJ; Ringer, R | 1 |
| Abdulaziz, O; Al-Hazmi, A; Alenazi, M; Aljuaid, A; Allahyani, M; Almehmadi, M; Alosimi, E; Alsiwiehri, N; Halawi, M; Rebh, F; Turjoman, A | 1 |
| Jalali, M; Jalali, Y; Kolosova, A; Kyselovic, J; Liptakova, A; Payer, J; Sturdik, I | 1 |
| Laupland, KB; Tabah, A | 1 |
| Chen, PL; Fukushige, M; Ko, WC; Lee, NY; Lin, WL; Morikawa, K; Syue, LS | 1 |
| Al-Qamari, A; Bardowski, L; Bulger, C; Churyla, A; Fiehler, M; Malczynski, M; Oakley, R; Qi, C; Rathod, SN; Tanna, SD; Tse, I; Zembower, TR | 1 |
| Coombs, GW; Daley, DA; Mowlaboccus, S; Shoby, P | 1 |
| Cabral, SM; Cosgrove, SE; Goodman, KE; Harris, AD; Magder, LS; Tamma, PD | 1 |
| Ahn, MY; Choi, JP; Kim, S; Oh, DH; Yang, E | 1 |
| Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
| Busch, DH; Dommasch, M; Feihl, S; Heim, M; Lahmer, T; Lukas, M; Querbach, C; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD; Treiber, M; Wallnöfer, F; Waschulzik, B; Wurst, M; Zink, A | 1 |
| Ghorat, F; Kalan Farmanfarma, K; Mahdavifar, N; Moslem, A; Nematshahi, M; Salehiniya, H | 1 |
| Baiu, I; Forgó, E; Kin, C; Weiser, TG | 1 |
| Berns, SA; Ershov, FI; Myasnikov, AL; Talyzin, PA | 1 |
| Ang, LW; Chan, CP; Looi, WL; Lye, DC; Ooi, XY; See, YP; Yeo, SC; Young, BE | 1 |
| Aghajani, F; Akhavizadegan, H; Dolatkhani, F; Faghir Gangi, M; Ghasemi, H; Ghazi, Z; Mousavi Movahed, SM; Nejadghaderi, SA | 1 |
| Barbouth, D; Hacker, S; Saad-Naguib, M; Tekin, M; Thorson, W | 1 |
1 review(s) available for vancomycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Update on Staphylococcus aureus bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; COVID-19; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
2 trial(s) available for vancomycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; COVID-19; Diarrhea; Fidaxomicin; Humans; Recurrence; Treatment Outcome; Vancomycin | 2022 |
[Interferon gamma in the treatment of patients with moderate COVID-19].
Topics: Aged; Ampicillin; Anti-Infective Agents; Anticoagulants; Azithromycin; Blood Pressure; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Humans; Hydroxychloroquine; Immunologic Factors; Interferon-gamma; Male; Middle Aged; Random Allocation; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vancomycin | 2021 |
15 other study(ies) available for vancomycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Comparison of the certified Copan eSwab system with commercially available cotton swabs for the detection of multidrug-resistant bacteria in rectal swabs.
Topics: COVID-19; Escherichia coli; Humans; Klebsiella pneumoniae; Pandemics; Prospective Studies; SARS-CoV-2; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Evaluation of Renal Function in COVID-19 Patients by Using Urinalysis Following the Administration of Vancomycin.
Topics: Coinfection; COVID-19; Female; Glycosuria; Hematuria; Humans; Ketosis; Kidney; Male; Prediabetic State; Proteinuria; Retrospective Studies; Urinalysis; Vancomycin | 2022 |
First report of nosocomial outbreak of vancomycin-resistant Enterococcus faecium infection among COVID-19 patients hospitalized in a non-intensive care unit ward in Slovakia.
Topics: Anti-Bacterial Agents; COVID-19; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; SARS-CoV-2; Slovakia; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed.
Topics: COVID-19; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Hand Hygiene; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin-resistant Enterococcus outbreak in a pre- and post-cardiothoracic transplant population: Impact of discontinuing multidrug-resistant organism surveillance during the coronavirus disease 2019 pandemic.
Topics: Anti-Bacterial Agents; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Pandemics; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Surveillance Outcome Program (AESOP).
Topics: Agar; Anti-Bacterial Agents; Bacteremia; COVID-19; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Northern Territory; Vancomycin | 2022 |
Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019-2020.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; COVID-19; Guideline Adherence; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2023 |
Increased incidence of teicoplanin-non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study.
Topics: Anti-Bacterial Agents; COVID-19; Humans; Incidence; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2023 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Stewardship; Aspergillosis; Azithromycin; Bacterial Infections; Cohort Studies; Coinfection; COVID-19; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Humans; Klebsiella Infections; Linezolid; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; SARS-CoV-2; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Vancomycin; Young Adult | 2021 |
The index case of COVID-19 in Northeastern Iran.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Contact Tracing; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Iran; Male; Quarantine; Respiratory Distress Syndrome; Ribavirin; SARS-CoV-2; Tomography, X-Ray Computed; Travel-Related Illness; Treatment Outcome; Vancomycin | 2020 |
Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19.
Topics: Aged; Anti-Bacterial Agents; Cecal Diseases; Cecum; Clostridioides difficile; COVID-19; Enterocolitis, Pseudomembranous; Humans; Intestinal Perforation; Male; SARS-CoV-2; Vancomycin | 2021 |
Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Comorbidity; COVID-19; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoxia; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study.
Topics: Acute Kidney Injury; Adult; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Female; Hospital Mortality; Hospitalization; Humans; Iran; Linezolid; Lopinavir; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome; Vancomycin | 2021 |
COVID-19 in a child with severe propionic acidemia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Child; COVID-19; Female; Humans; Polymerase Chain Reaction; Propionic Acidemia; SARS-CoV-2; Treatment Outcome; Vancomycin; Vomiting | 2021 |